Orchid Pharma Ltd.

Orchid Pharma zooms on signing licensing and supply agreement with Pharmasyntez

Under the agreement, Pharmasyntez will hold the exclusive rights to register and commercialize Exblifep in Russia, with Orchid supplying the finished dosage form

Orchid Pharma signs licensing and supply agreement with Pharmasyntez

Under the agreement, Pharmasyntez will hold the exclusive rights to register and commercialize Exblifep in Russia, with Orchid supplying the finished dosage form

Orchid Pharma informs about investor presentation

Orchid Pharma reports Profit after tax of Rs 306.03 Mln, in the March 2026 quarter